GSA Capital Partners’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,884	Closed	-$391K	–	2003
2025 Q3	$391K	Buy	+5,884	New	+$334K	0.03%	1022
2025 Q2	–	Sell	-11,963	Closed	-$579K	–	2075
2025 Q1	$579K	Buy	+11,963	New	+$501K	0.05%	694
2024 Q4	–	Sell	-25,095	Closed	-$1.13M	–	1948
2024 Q3	$1.13M	Buy	25,095 +66	+0.3%	+$2.67K	0.09%	393
2024 Q2	$867K	Sell	25,029 -30,330	-55%	-$888K	0.06%	599
2024 Q1	$1.6M	Buy	55,359 +35,571	+180%	+$968K	0.13%	199
2023 Q4	$454K	Buy	+19,788	New	+$346K	0.04%	859
2023 Q1	–	Sell	-55,839	Closed	-$609K	–	1849
2022 Q4	$609K	Buy	55,839 +43,694	+360%	+$369K	0.08%	480
2022 Q3	$102K	Buy	+12,145	New	+$115K	0.01%	1361
2020 Q2	–	Sell	-30,928	Closed	-$218K	–	1019
2020 Q1	$218K	Sell	30,928 -36,258	-54%	-$272K	0.06%	698
2019 Q4	$474K	Buy	+67,186	New	+$667K	0.06%	688